{
  "pmcid": "12083446",
  "sha256": "c2f98bc119bea25f16a61d360c60774a092f06fc91b26f11659a0566e0e384f5",
  "timestamp_utc": "2025-11-09T15:29:51.722579+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.193781512605046,
    "reading_ease": 30.70892156862746,
    "word_count": 272
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution, between January 2017 and February 2020."
      },
      "Intervention": {
        "score": 2,
        "evidence": "TTFM was assessed in 430 patients (TTFM group). They were compared with 480 patients without TTFM assessment (no TTFM group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study was to evaluate the impact of transit-time flow measurement (TTFM) on early postoperative outcomes in total arterial coronary revascularization."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "Primary end point was the occurrence of in-hospital major cardiac adverse events (MACE)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "910 patients undergoing isolated total arterial coronary artery bypass grafting with internal thoracic arteries (ITAs) at our institution, between January 2017 and February 2020."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "TTFM was protective against MACE occurrence (odds ratios 0.46, 95% confidence interval 0.23â€“0.85, P = 0.016)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Six (1.4%) patients in the TTFM group versus no patient in the no TTFM group underwent intraoperative graft revision because of unsatisfying flow values ( P = 0.011)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}